Table 3. MACEs between men and women.
| All patients |
Age group, yrs |
||||||
| Men n = 12,562 | Women n = 4459 | P-value | < 60 n = 7079 OR* | 60–69 n = 4050 | 70–79 n = 4203 | ≥ 80 n = 1689 | |
| In-hospital mortality | 590 (4.7%) | 462 (10.4%) | < 0.001 | 2.41† | 1.39† | 1.44† | 1.08 |
| Cardiac death | 467 (3.7%) | 359 (8.1%) | < 0.001 | 1.91† | 1.38† | 1.47† | 1.04 |
| Non-cardiac death | 123 (1.0%) | 103 (2.3%) | < 0.001 | 4.23† | 1.36 | 1.26 | 1.18 |
| Before 30 days | |||||||
| All cause death | 621 (4.9%) | 483 (10.8%) | < 0.001 | 2.50† | 1.32 | 1.40† | 1.10 |
| Cardiac death | 488 (3.9%) | 381 (8.5%) | < 0.001 | 2.07† | 1.37† | 1.46† | 1.09 |
| Non-cardiac death | 133 (1.1%) | 102 (2.3%) | < 0.001 | 3.94† | 1.09 | 1.14 | 1.09 |
| Recurrent myocardial infarction | 22 (0.2%) | 8 (0.2%) | 0.925 | 1.67 | 0.47 | - | 1.14 |
| Repeat revascularization | 35 (0.3%) | 12 (0.3%) | 0.952 | - | 1.61 | 1.25 | 1.52 |
| MACEs | 678 (5.4%) | 503 (11.3%) | < 0.001 | 2.15† | 1.30 | 1.42† | 1.11 |
| 12 months follow-up | |||||||
| All cause death | 774 (6.2%) | 576 (12.9%) | < 0.001 | 2.36† | 1.31† | 1.33† | 1.01 |
| Cardiac death | 566 (4.5%) | 436 (9.8%) | < 0.001 | 2.10† | 2.75† | 1.44† | 1.00 |
| Non-cardiac death | 208 (1.7%) | 140 (3.1%) | < 0.001 | 2.84† | 0.96 | 1.03 | 1.03 |
| Recurrent myocardial infarction | 49 (0.4%) | 23 (0.5%) | 0.242 | 0.83 | 0.47 | 4.19† | 1.14 |
| Repeat revascularization | 234 (1.9%) | 65 (1.5%) | 0.096 | 0.62 | 1.01 | 0.87 | 0.98 |
| MACEs | 1057 (8.4%) | 664 (14.9%) | < 0.001 | 1.55† | 1.22 | 1.31† | 1.01 |
*The OR is for the comparison of women with men. †The OR is significant between women and men. Data were presented as n (%). MACEs: major adverse cardiovascular events; OR: odds ratios.